|
VKTX Viking Therapeutics Inc 1607678 |
| Balance Sheet |
|
Current Assets
|
936,649,000 |
|
Assets
|
937,888,000 |
|
Current Liabilities
|
25,685,000 |
|
Liabilities
|
26,440,000 |
|
Equity
|
911,448,000 |
|
Shares Out
|
110,796,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-56,609,000 |
|
Investing Cash Flow
|
-559,950,000 |
| Market Analysis |
Market Cap
|
6,964,006,342 |
|
Price
|
32.65 |
|
BVPS
|
8.23 |
|
PB
|
3.97 |
|
EPS
|
-0.94 |
|
PS
|
3.04 |
|
FCF
|
-616,559,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VKTX documents filed with the SEC.
VKTX Filings
Clear
